BusinessSummit Highlights DMD Biomarker Validation Data and Phase 2 Clinical Trial Baseline Characteristics in Presentations at 22nd WMS CongressBy Nasdaq OMXOct 4, 2017, 11:00 AM UTC
BusinessHemispherx Encouraged by Cytokine Biomarker Discovery Which May Lead to a Diagnostic for Chronic Fatigue SyndromeBy Nasdaq OMXAug 4, 2017, 12:30 PM UTC
BusinessBiothera Pharmaceuticals Announces Presentation of Clinical Data Supporting Use of a Patient Selection Biomarker for its Phase 2 Cancer ImmunotherapyBy Nasdaq OMXFeb 24, 2017, 7:24 PM UTC
BusinessSummit Therapeutics Presents Preclinical DMD Data at the 21st International Congress of the World Muscle SocietyBy Nasdaq OMXOct 6, 2016, 11:00 AM UTC
BusinessSummit Announces Publication on Biomarkers to Quantify Utrophin Protein and Regeneration of Muscle Fibres in DMDBy Nasdaq OMXMar 15, 2016, 11:00 AM UTC
